124 related articles for article (PubMed ID: 1586640)
1. Intra-abdominal panniculitis can mimic recurrent stomach carcinoma.
MacVicar D; Husband JE; Taylor R; Menzies-Gow N; Cunningham D
Clin Oncol (R Coll Radiol); 1992 May; 4(3):194-5. PubMed ID: 1586640
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
Strickland AH; Karapetis CS; Yip D; Harper PG
Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
[No Abstract] [Full Text] [Related]
3. Standard chemotherapy for gastric carcinoma: is it a myth?
Tebbutt NC; Norman A; Hill M; Cunningham D
J Clin Oncol; 2001 May; 19(10):2765-7. PubMed ID: 11352971
[No Abstract] [Full Text] [Related]
4. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A
Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemotherapy of gastric carcinoma].
Parisi V; Daniele B; Perrone F; DeMaio L; Delrio P; Palaia R
Suppl Tumori; 2002; 1(3):S27-9. PubMed ID: 12415782
[No Abstract] [Full Text] [Related]
6. [Effective combination chemotherapy for a recurrent case of carcinoma of the remnant stomach].
Kaneko T; Konno H; Tanaka T; Kamiya K; Baba M; Oota M; Kondo K; Shouji T; Igarashi A; Nakamura S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):535-8. PubMed ID: 11329791
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
Melcher AA; Mort D; Maughan TS
Br J Cancer; 1996 Nov; 74(10):1651-4. PubMed ID: 8932350
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin, cisplatin and intermittent continuous infusion of 5-fluorouracil in advanced gastric cancer: an effective regimen?
Poorter RL; Bakker PJ; Taat CW; Bartelsman JF; Veenhof CH
Eur J Cancer; 1994; 30A(9):1404. PubMed ID: 7999436
[No Abstract] [Full Text] [Related]
9. Epirubicin, Cisplatin, and protracted venous-infusion Fluorouracil in advanced esophagogastric cancer.
Leonard GD; Zhuang SH; Grem JL
J Clin Oncol; 2002 Oct; 20(19):4124-5; author reply 4125-6. PubMed ID: 12351613
[No Abstract] [Full Text] [Related]
10. Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?
Ilson DH
J Clin Oncol; 2002 Apr; 20(8):1962-4. PubMed ID: 11956251
[No Abstract] [Full Text] [Related]
11. Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma. The MRC Gastric Cancer Working Party and the British Stomach Cancer Group.
Allum WH
Br J Surg; 1995 Apr; 82(4):565. PubMed ID: 7542143
[No Abstract] [Full Text] [Related]
12. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
13. [The use of endolymphatic chemotherapy in patients with metastatic stomach cancer].
Bondar' GV; Zabudkin AF; Bukhteev SV
Klin Khir (1962); 1994; (5):3-5. PubMed ID: 7807894
[TBL] [Abstract][Full Text] [Related]
14. Locally recurrent adenoid cystic carcinoma of the left antrum: response to epirubicin, cisplatin and 5-fluorouracil.
Ferguson MJ; Dewar JA
Clin Oncol (R Coll Radiol); 2001; 13(3):236-7. PubMed ID: 11527304
[No Abstract] [Full Text] [Related]
15. FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) in advanced gastric cancer.
González-Barón M; Feliu J; Espinosa E; García-Girón C; Chacon I; Garrido P; Colmenarejo A
Eur J Cancer; 1994; 30A(11):1733-4. PubMed ID: 7833158
[No Abstract] [Full Text] [Related]
16. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial.
Tsavaris NB; Tentas K; Kosmidis P; Mylonakis N; Sakelaropoulos N; Kosmas C; Lisaios B; Soumilas A; Mandrekois D; Tsetis A; Klonaris C
Am J Clin Oncol; 1996 Oct; 19(5):517-21. PubMed ID: 8823483
[TBL] [Abstract][Full Text] [Related]
18. Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.
Thuss-Patience PC; Kretzschmar A; Krenn V; Dörken B; Reichardt P
Onkologie; 2003 Feb; 26(1):63-5. PubMed ID: 12624520
[TBL] [Abstract][Full Text] [Related]
19. Malignant acanthosis nigricans: potential role of chemotherapy.
Anderson SH; Hudson-Peacock M; Muller AF
Br J Dermatol; 1999 Oct; 141(4):714-6. PubMed ID: 10583123
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Webb A; Cunningham D; Scarffe JH; Harper P; Norman A; Joffe JK; Hughes M; Mansi J; Findlay M; Hill A; Oates J; Nicolson M; Hickish T; O'Brien M; Iveson T; Watson M; Underhill C; Wardley A; Meehan M
J Clin Oncol; 1997 Jan; 15(1):261-7. PubMed ID: 8996151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
